Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Cocrystal Pharma Inc COCP

Healthcare Biotechnology
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:COCP)

Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference

GlobeNewswire 3 days ago

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire November 14, 2025

Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire October 30, 2025

Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program

GlobeNewswire October 27, 2025

Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

GlobeNewswire October 2, 2025

Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire September 15, 2025

Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire September 12, 2025

Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference

GlobeNewswire September 12, 2025

Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment

GlobeNewswire September 8, 2025
View More News ››

Opinion & Analysis (NDAQ:COCP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:COCP)

This stock is still cheap.

It should be trading at a much higher price per share.
coolfooldumbguy - January 8, 2025

COCP ....... Early a.m runner on NR

Now in PB mode.......$1.34 Look for support sub $1.30.....stops save portfolios Cheers !
Iseneschal - July 29, 2021

COCP up in pre-market....on watch

Seems like ever since Feb 2020.....it pops on volume evry few months. Here we go again. ps: I don't chase  Cheers !
Iseneschal - May 4, 2021

RE:RE:Q3 EPS: Pipeline Remains on Track

http://www.cocrystalpharma.com/news/press-releases/detail/115/cocrystal-pharma-reports-2020-financial-results-provides
Popeye82 - April 27, 2021

RE:Q3 EPS: Pipeline Remains on Track

http://www.cocrystalpharma.com/news/press-releases/detail/114/cocrystal-pharma-extends-drug-discovery-collaboration-with
Popeye82 - April 27, 2021

Q3 EPS: Pipeline Remains on Track

Q3 EPS: Pipeline Remains on Track https://www.channelchek.com/news-channel/Cocrystal_Pharma_Inc.__COCP____Q3_EPS_Pipeline_Remains_on...
schoolofrock - November 17, 2020
View more Bullboard ››

Sekur Private Data Ltd.

Sekur Private Data Ltd.

Sekur Private Data Ltd. operates as a cybersecurity and internet privacy provider of Swiss hosted solutions for secure ...
View More »